|
100
|
236
|
6fauA |
Crystal structure of c-terminal modified tau peptide-hybrid 4.2e-i with 14-3-3sigma |
|
101
|
235
|
5btvA |
Crystal structure of human 14-3-3 sigma in complex with a tau-protein peptide surrounding ps324 |
|
100
|
235
|
4dhqA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
96
|
234
|
4dauA |
Structure of 14-3-3 sigma in complex with padi6 14-3-3 binding motif i |
|
101
|
235
|
4dhpA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
102
|
235
|
4dhuA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
102
|
235
|
4dhrA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
100
|
235
|
4dhsA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
99
|
235
|
4dhnA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
100
|
235
|
4dhoA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
100
|
235
|
4dhmA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
102
|
235
|
4dhtA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
97
|
234
|
4datA |
Structure of 14-3-3 sigma in complex with padi6 14-3-3 binding motif ii |
|
100
|
235
|
3ux0A |
Crystal structure of human 14-3-3 sigma in complex with task-3 peptide and stabilizer fusicoccin h |
|
99
|
235
|
3u9xA |
Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteins |
|
101
|
235
|
3t0lA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
102
|
235
|
3t0mA |
Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening |
|
102
|
235
|
3sp5A |
Crystal structure of human 14-3-3 sigma c38v/n166h in complex with task-3 peptide and stabilizer cotylenol |
|
104
|
236
|
3sprA |
Crystal structure of human 14-3-3 sigma c38v/n166h in complex with task-3 peptide and stabilizer fc-thf |
|
102
|
236
|
3smnA |
Crystal structure of human 14-3-3 sigma c38n/n166h in complex with task-3 peptide and stabilizer fusicoccin a-thf |
|
103
|
236
|
3smmA |
Crystal structure of human 14-3-3 sigma c38n/n166h in complex with task-3 peptide and stabilizer fusicoccin j aglycone |
|
97
|
236
|
3smkA |
Crystal structure of human 14-3-3 sigma c38v/n166h in complex with task-3 peptide and stabilizer cotylenin a |
|
102
|
235
|
3smoA |
Crystal structure of human 14-3-3 sigma c38v/n166h in complex with task-3 peptide and stabilizer fusicoccin j aglycone |
|
98
|
236
|
3smlA |
Crystal structure of human 14-3-3 sigma c38n/n166h in complex with task-3 peptide and stabilizer fusicoccin a aglycone |
|
93
|
236
|
5oehA |
Molecular tweezers modulate 14-3-3 protein-protein interactions. |
|
90
|
235
|
5oegA |
Molecular tweezers modulate 14-3-3 protein-protein interactions |
|
98
|
236
|
5n5tA |
14-3-3 sigma in complex with taz ps89 peptide and fragment nv2 |
|
100
|
236
|
5mycA |
Crystal structure of human 14-3-3 sigma in complex with lrrk2 peptide ps910 |
|
0
|
12
|
5mhcP |
Crystal structure of 14-3-3sigma and a p53 c-terminal 12-mer synthetic phosphopeptide |
|
102
|
236
|
5hf3A |
Crystal structure of c-terminal modified tau peptide-hybrid 201d with 14-3-3sigma |
|
102
|
236
|
4y32A |
Crystal structure of c-terminal modified tau peptide-hybrid 109b with 14-3-3sigma |
|
102
|
236
|
4y3bA |
Crystal structure of c-terminal modified tau peptide-hybrid 201d with 14-3-3sigma |
|
100
|
236
|
4y5iA |
Crystal structure of c-terminal modified tau peptide-hybrid 126b with 14-3-3sigma |
|
103
|
236
|
4qliA |
A novel phospho-switch in the linker region of the snail zinc finger protein which regulates 14-3-3 association, dna binding and epithelial-mesenchymal differentiation |
|
101
|
236
|
4jc3A |
14-3-3 protein interaction with estrogen receptor alpha provides a novel drug target interface |
|
100
|
235
|
4ieaA |
14-3-3 isoform sigma in complex with a phosphorylated c-raf peptide |
|
99
|
236
|
4jddA |
14-3-3 protein interaction with estrogen receptor alpha provides a novel drug target interface |
|
97
|
234
|
4fr3A |
Crystal structure of human 14-3-3 sigma in complex with task-3 peptide and stabilizer 16-o-me-fc-h |
|
100
|
236
|
4fl5A |
Crystal structure of human 14-3-3 sigma in complex with a tau-protein peptide surrounding ps214 |
|
105
|
235
|
3p1nA |
Crystal structure of human 14-3-3 sigma in complex with task-3 peptide |
|
101
|
236
|
3p1sA |
Crystal structure of human 14-3-3 sigma c38n/n166h in complex with task-3 peptide and stabilizer fusicoccin a |
|
101
|
236
|
3p1qA |
Crystal structure of human 14-3-3 sigma c38n/n166h in complex with task-3 peptide and stabilizer fusicoccin a |
|
98
|
235
|
3p1oA |
Crystal structure of human 14-3-3 sigma in complex with task-3 peptide and stabilisator fusicoccin a |
|
102
|
236
|
3p1rA |
Crystal structure of human 14-3-3 sigma c38v/n166h in complex with task-3 peptide |
|
106
|
236
|
3p1pA |
Crystal structure of human 14-3-3 sigma c38n/n166h in complex with task-3 peptide |
|
89
|
234
|
3o8iA |
Structure of 14-3-3 isoform sigma in complex with a c-raf1 peptide and a stabilizing small molecule fragment |
|
102
|
236
|
3mhrA |
14-3-3 sigma in complex with yap ps127-peptide |
|
0
|
10
|
3mhrP |
14-3-3 sigma in complex with yap ps127-peptide |
|
103
|
236
|
3lw1A |
Binary complex of 14-3-3 sigma and p53 pt387-peptide |
|
102
|
236
|
3iqvA |
Crystal structure of human 14-3-3 sigma in complex with raf1 peptide (6mer) and stabilisator fusicoccin |
